Therapeutic efficacy of N-methyl D-aspartate antagonist amantadine in febrile catatonia.
Northoff
G
G
Lins
H
H
Böker
H
H
Danos
P
P
Bogerts
B
B
D000328:Adult; D000547:Amantadine / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D002389:Catatonia / Q000188:drug therapy* / Q000209:etiology; D015259:Dopamine Agents / Q000627:therapeutic use*; D018690:Excitatory Amino Acid Agonists / Q000627:therapeutic use*; D005334:Fever / Q000150:complications*; D006801:Humans; D008297:Male; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy
D015259:Dopamine Agents; D018690:Excitatory Amino Acid Agonists; D016202:N-Methylaspartate; D000547:Amantadine